Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07685977

Advanced Robotic Techniques and Rapid Onsite Evaluation for Minimally Invasive Diagnosis and Next-Generation Sequencing.

Conditions: Peripheral Pulmonary Lesions (PPLs)

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 400
Sponsor: Vanderbilt University Medical Center

Location: Northwestern Memorial Hospital Chicago Illinois

Summary

ARTEMIS is a multicenter randomized controlled trial. The goal is to understand whether rapid onsite evaluation during robotic assisted bronchoscopy improves the diagnostic performance of the procedure or not.

Eligibility Criteria

Inclusion Criteria: * ≥ 18 years of age at time of bronchoscopy * Undergoing robotic assisted bronchoscopy to biopsy a pulmonary lesion Exclusion Criteria: * Declines to participate or inability to provide informed consent. * Clinician determination that the use of ROSE is required or contraindicated for the optimal care of an individual patient * Patient enrolled in another trial that requires ROSE for PPL biopsy * Patient previously consented for this trial * Pregnant or incarcerated patients

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07685977). StuddyBuddy aggregates publicly available trial information.